Md. vaccine company raises another $16M for cancer programs after a strong 2020
The latest funding comes on top of $61.3 million in new funding the local biotech raised in April.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Sara Gilgore Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Cancer Vaccines | Funding | Health Management | Vaccines